NasdaqGS - Delayed Quote USD
IO Biotech, Inc. (IOBT)
1.3500
-0.1500
(-10.00%)
At close: June 13 at 4:00:02 PM EDT
1.3600
+0.01
+(0.74%)
After hours: June 13 at 7:21:58 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 2 |
| Avg. Estimate | -0.3 | -0.25 | -1.14 | -0.99 |
| Low Estimate | -0.3 | -0.25 | -1.14 | -0.99 |
| High Estimate | -0.3 | -0.25 | -1.14 | -0.98 |
| Year Ago EPS | -0.28 | -0.34 | -1.35 | -1.14 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 5 |
| Avg. Estimate | -- | -- | -- | 19.27M |
| Low Estimate | -- | -- | -- | 4.7M |
| High Estimate | -- | -- | -- | 42.26M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.33 | -0.35 | -0.38 | -0.23 |
| EPS Actual | -0.28 | -0.34 | -0.46 | -0.32 |
| Difference | 0.05 | 0.01 | -0.07 | -0.09 |
| Surprise % | 14.39% | 2.80% | -18.70% | -37.61% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.3 | -0.25 | -1.14 | -0.99 |
| 7 Days Ago | -0.24 | -0.29 | -1.17 | -1.25 |
| 30 Days Ago | -0.24 | -0.29 | -1.17 | -1.25 |
| 60 Days Ago | -0.24 | -0.29 | -1.17 | -1.25 |
| 90 Days Ago | 0 | 0 | -1.29 | -1.51 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IOBT | -6.19% | 26.51% | 15.58% | 13.60% |
| S&P 500 | 13.13% | 2.43% | 7.54% | 14.06% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/5/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/6/2024 |
| Maintains | Morgan Stanley: Overweight to Overweight | 9/16/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/16/2024 |
Related Tickers
CMPX Compass Therapeutics, Inc.
2.4100
0.00%
OVID Ovid Therapeutics Inc.
0.2802
-3.15%
ATRA Atara Biotherapeutics, Inc.
8.82
+1.26%
GOSS Gossamer Bio, Inc.
1.2400
-2.36%
MIST Milestone Pharmaceuticals Inc.
1.6500
-1.79%
RZLT Rezolute, Inc.
4.2000
-4.55%
PTNT Palatin Technologies, Inc.
0.1000
0.00%
GLYC GlycoMimetics, Inc.
0.1570
-5.42%
STRO Sutro Biopharma, Inc.
0.7991
-1.50%
CHRS Coherus Oncology, Inc.
0.7617
-3.63%